Profuse Announces 1-For-25 Reverse Stock Split, Effective July 7
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ: PFSA ), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed an amendment to its amended and restated certificate of incorporation wit